Strata Critical Medical, Inc. (SRTA) vs Tilray Brands, Inc. (TLRY)

A side-by-side comparison of Strata Critical Medical, Inc. and Tilray Brands, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — SRTA vs TLRY

growth of $100 · dividends reinvested · last 7y
SRTA -50.7% (-9.6%/yr)TLRY -98.3% (-44.3%/yr)SRTA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120232025$49$2
SRTA TLRY

SRTA vs TLRY: by the numbers

  • •TLRY is the larger company ($423M vs $411M market cap).
  • •SRTA is profitable (15.71% net margin) while TLRY runs a net loss (-12.90%).
  • •SRTA grew revenue faster over the past five years (46.05% vs 17.11% CAGR).

Metrics side by side

Valuation

MetricSRTATLRY
P/E ratio9.54N/A
P/S ratio1.610.37
P/B ratio1.470.26
EV / EBITDAN/A22.89

Profitability

MetricSRTATLRY
Gross margin20.56%27.57%
Operating margin-7.97%-5.18%
Net margin15.71%-12.90%
ROE14.40%-9.23%
ROIC-7.11%-2.98%

Growth (annualized)

MetricSRTATLRY
Revenue CAGR (5Y)46.05%17.11%
Total return CAGR (5Y)-13.77%-49.30%

Frequently asked

Which has grown faster, SRTA or TLRY?
Over the past five years, SRTA grew revenue faster — SRTA at a 46.05% CAGR versus TLRY at 17.11%.
Is SRTA or TLRY more profitable?
SRTA runs the higher net margin — SRTA at 15.71% versus TLRY at -12.90%.
How have SRTA and TLRY total returns compared?
Over the past 5 years, SRTA delivered -13.77% and TLRY delivered -49.30% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.